156 related articles for article (PubMed ID: 19952855)
1. Automated radiolabelling of monoclonal antibodies with the Modular Lab system.
Ellison D; Kaufman J; Mather SJ
Nucl Med Commun; 2010 Feb; 31(2):173-7. PubMed ID: 19952855
[TBL] [Abstract][Full Text] [Related]
2. Fully Automated
Poot AJ; Adamzek KWA; Windhorst AD; Vosjan MJWD; Kropf S; Wester HJ; van Dongen GAMS; Vugts DJ
J Nucl Med; 2019 May; 60(5):691-695. PubMed ID: 30530830
[TBL] [Abstract][Full Text] [Related]
3. Automated module radiolabeling of peptides and antibodies with gallium-68, lutetium-177 and iodine-131.
De Decker M; Turner JH
Cancer Biother Radiopharm; 2012 Feb; 27(1):72-6. PubMed ID: 22149590
[TBL] [Abstract][Full Text] [Related]
4. A fully automated synthesis for the preparation of 68Ga-labelled peptides.
Decristoforo C; Knopp R; von Guggenberg E; Rupprich M; Dreger T; Hess A; Virgolini I; Haubner R
Nucl Med Commun; 2007 Nov; 28(11):870-5. PubMed ID: 17901771
[TBL] [Abstract][Full Text] [Related]
5. Automation of labelling of Lipiodol with high-activity generator-produced 188Re.
Lepareur N; Ardisson V; Noiret N; Boucher E; Raoul JL; Clément B; Garin E
Appl Radiat Isot; 2011 Feb; 69(2):426-30. PubMed ID: 21106381
[TBL] [Abstract][Full Text] [Related]
6. Radiolabelling, quality control and radiochemical purity assessment of the Octreotide analogue 68Ga DOTA NOC.
Di Pierro D; Rizzello A; Cicoria G; Lodi F; Marengo M; Pancaldi D; Trespidi S; Boschi S
Appl Radiat Isot; 2008 Aug; 66(8):1091-6. PubMed ID: 18226535
[TBL] [Abstract][Full Text] [Related]
7. One-step high-radiochemical-yield synthesis of [18F]FP-CIT using a protic solvent system.
Lee SJ; Oh SJ; Chi DY; Kang SH; Kil HS; Kim JS; Moon DH
Nucl Med Biol; 2007 May; 34(4):345-51. PubMed ID: 17499723
[TBL] [Abstract][Full Text] [Related]
8. Methods for radiolabelling of monoclonal antibodies.
Tolmachev V; Orlova A; Andersson K
Methods Mol Biol; 2014; 1060():309-30. PubMed ID: 24037848
[TBL] [Abstract][Full Text] [Related]
9. Preparation and evaluation of the rhenium-188-labelled anti-NCA antigen monoclonal antibody BW 250/183 for radioimmunotherapy of leukaemia.
Seitz U; Neumaier B; Glatting G; Kotzerke J; Bunjes D; Reske SN
Eur J Nucl Med; 1999 Oct; 26(10):1265-73. PubMed ID: 10541824
[TBL] [Abstract][Full Text] [Related]
10. Fully automated synthesis and coupling of [(18) F]FBEM to glutathione using the iPHASE FlexLab module.
Ackermann U; Plougastel L; Wichmann C; Goh YW; Yeoh SD; Poniger SS; Tochon-Danguy HJ; Scott AM
J Labelled Comp Radiopharm; 2014 Feb; 57(2):115-20. PubMed ID: 24395455
[TBL] [Abstract][Full Text] [Related]
11. Semiautomated labelling and fractionation of yttrium-90 and lutetium-177 somatostatin analogues using disposable syringes and vials.
Asti M; Atti G; Iori M; Farioli D; Filice A; Versari A
Nucl Med Commun; 2012 Nov; 33(11):1144-52. PubMed ID: 22889932
[TBL] [Abstract][Full Text] [Related]
12. Design and manufacture of monoclonal antibodies for radioimmunotherapy.
Hale G; Berrie E; Bird P
Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):258-66. PubMed ID: 15640789
[TBL] [Abstract][Full Text] [Related]
13. Labelling of monoclonal antibodies 10B, 8C, and M2A with indium-111.
Reilly R; Sheldon K; Marks A; Houle S
Int J Rad Appl Instrum A; 1989; 40(4):279-83. PubMed ID: 2543652
[TBL] [Abstract][Full Text] [Related]
14. A kit formulated under good manufacturing practices for labeling human epidermal growth factor with 111In for radiotherapeutic applications.
Reilly RM; Scollard DA; Wang J; Mondal H; Chen P; Henderson LA; Bowen BM; Vallis KA
J Nucl Med; 2004 Apr; 45(4):701-8. PubMed ID: 15073268
[TBL] [Abstract][Full Text] [Related]
15. Fully automated radiosynthesis of [¹¹C]PBR28, a radiopharmaceutical for the translocator protein (TSPO) 18 kDa, using a GE TRACERlab FXC-Pro.
Hoareau R; Shao X; Henderson BD; Scott PJ
Appl Radiat Isot; 2012 Aug; 70(8):1779-83. PubMed ID: 22503515
[TBL] [Abstract][Full Text] [Related]
16. Radiolabelling of peptides for PET, SPECT and therapeutic applications using a fully automated disposable cassette system.
Petrik M; Knetsch PA; Knopp R; Imperato G; Ocak M; von Guggenberg E; Haubner R; Silbernagl R; Decristoforo C
Nucl Med Commun; 2011 Oct; 32(10):887-95. PubMed ID: 21876399
[TBL] [Abstract][Full Text] [Related]
17. Comparative serum stability of radiochelates for antibody radiopharmaceuticals.
Cole WC; DeNardo SJ; Meares CF; McCall MJ; DeNardo GL; Epstein AL; O'Brien HA; Moi MK
J Nucl Med; 1987 Jan; 28(1):83-90. PubMed ID: 3794813
[TBL] [Abstract][Full Text] [Related]
18. Labelling of
Iori M; Capponi PC; Rubagotti S; Esposizione LR; Seemann J; Pitzschler R; Dreger T; Formisano D; Grassi E; Fioroni F; Versari A; Asti M
Contrast Media Mol Imaging; 2017; 2017():8160134. PubMed ID: 29097938
[TBL] [Abstract][Full Text] [Related]
19. Antiangiogenic Human Monoclonal Antibody Ramucirumab Radiolabelling:
Janousek J; Barta P; Novy Z; Zilkova K; Trejtnar F
Anticancer Res; 2019 Feb; 39(2):735-744. PubMed ID: 30711952
[No Abstract] [Full Text] [Related]
20. Application of robotics to radiopharmaceutical preparation: controlled synthesis of fluorine-18 16 alpha-fluoroestradiol-17 beta.
Brodack JW; Kilbourn MR; Welch MJ; Katzenellenbogen JA
J Nucl Med; 1986 May; 27(5):714-21. PubMed ID: 3486960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
